13F Data
Security · CUSIP 00860C102

AGOMAB THERAPEUTICS NV

SPONSORED ADS · institutional ownership from 13F filings
13F holders
32
Shares held
23.4M
Value held
$245.3M
New / sold out
32 / 0
Added / reduced
0 / 0
net +23.4M shares

13F holders by quarter

Q1 2026: 32Q2 2026: 34Q3 2026: 11
Q1 2026Q3 2026

Net shares bought by existing holders

Q1 2026: 23.4MQ2 2026: 4.2MQ3 2026: 425.8K
Q1 2026Q3 2026

Top holders · Q1 2026

ManagerSharesValue% of portfolio
EQT Fund Management S.a r.l.5,141,992$53.9M5.28%
Sanofi2,783,096$29.2M8.69%
Cormorant Asset Management, LP2,465,348$25.9M1.30%
TCG Crossover Management, LLC2,053,233$21.5M0.62%
FEDERATED HERMES, INC.1,618,000$17.0M0.03%
Casdin Capital, LLC1,550,000$16.3M1.23%
ANDERA PARTNERS1,538,702$16.1M9.12%
FMR LLC1,458,677$15.3M0.00%
Nantahala Capital Management, LLC1,200,000$12.9M0.47%
Aberdeen Group plc707,656$7.4M0.01%
22 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest buyers

ManagerChangeShares changeChange %
EQT Fund Management S.a r.l.New+5,141,992–
SanofiNew+2,783,096–
Cormorant Asset Management, LPNew+2,465,348–
TCG Crossover Management, LLCNew+2,053,233–
FEDERATED HERMES, INC.New+1,618,000–
Casdin Capital, LLCNew+1,550,000–
ANDERA PARTNERSNew+1,538,702–
FMR LLCNew+1,458,677–
Nantahala Capital Management, LLCNew+1,200,000–
Aberdeen Group plcNew+707,656–
22 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sellers

Nothing to show.